Chris Price

Chris Price is an accomplished professional in the biopharmaceutical industry with extensive experience in business development and licensing. Currently serving as the Head of Business Development at invoX Pharma Limited since August 2021, Chris has held senior roles at notable companies such as Sandoz as Director of Global Business Development & Licensing, Biopharmaceuticals, and Novartis in Search & Evaluation for Immunology, Hepatology, and Dermatology. Previous positions also include Director of Corporate Licensing at Grünenthal and various roles at BioMarin and Bristol-Myers Squibb. Chris holds an MBA in Strategy and Entrepreneurship from UNC Kenan-Flagler Business School, a Ph.D. in Chemistry from the University of Michigan, and a B.S. in Chemistry from UC Santa Barbara.